Vicki Brower. Show Affiliations »
Abstract
Mesh: See more » Angiogenesis Inhibitors/pharmacologyAngiogenesis Inhibitors/therapeutic useAnimalsAntibodies, Monoclonal/pharmacologyAntibodies, Monoclonal, HumanizedBenzenesulfonates/pharmacologyBevacizumabBiomarkers, Tumor/metabolismCytokines/metabolismDisease-Free SurvivalEndothelial Cells/drug effectsHumansIndoles/pharmacologyNeoplasms/blood supplyNeoplasms/drug therapyNeoplasms/metabolismNeoplasms/mortalityNeoplasms/pathologyNiacinamide/analogs & derivativesPhenylurea CompoundsPyridines/pharmacologyPyrroles/pharmacologySorafenibSunitinibSurvival AnalysisVascular Endothelial Growth Factor A/metabolism
Substances: See more » Angiogenesis InhibitorsAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedBenzenesulfonatesBiomarkers, TumorCytokinesIndolesPhenylurea CompoundsPyridinesPyrrolesVascular Endothelial Growth Factor ANiacinamideBevacizumabSorafenibSunitinib
Year: 2009 PMID: 19509354 DOI: 10.1093/jnci/djp171
Source DB: PubMed Journal: J Natl Cancer Inst ISSN: 0027-8874 Impact factor: 13.506